Switching biological agents for psoriasis in secondary care: a single-centre, retrospective, open-label study. [electronic resource]
Producer: 20150528Description: 989-90 p. digitalISSN:- 1365-2133
- Adalimumab
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Biological Factors -- therapeutic use
- Dermatologic Agents -- therapeutic use
- Drug Substitution
- Etanercept
- Female
- Humans
- Immunoglobulin G -- therapeutic use
- Infliximab
- Male
- Middle Aged
- Psoriasis -- drug therapy
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Retrospective Studies
- Secondary Care -- methods
- Ustekinumab
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.